Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Sep 16, 2021; 13(9): 371-381
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.371
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.371
Table 2 Univariate analysis of outcomes between propensity weighted cohort of patients with and without cystic fibrosis who underwent laparoscopic cholecystectomy in the Nationwide Inpatient Sample 2002-2014
Without cystic fibrosis (n = 722) | With cystic fibrosis (n = 731) | ||||
n | % | n | % | P value | |
Mortality1 | ≤ 10 | ≤ 1.39 | ≤ 10 | ≤ 1.37 | 0.662 |
Length of stay (mean ± SE) | 5.18 | 0.33 | 9.36 | 0.89 | < 0.001 |
Cost ($) (mean ± SE) | 14103 | 842 | 25891 | 3859 | 0.003 |
Pulmonary complications | 29 | 4.05 | 49 | 6.64 | 0.109 |
Surgical complications | 16 | 2.27 | 33 | 4.48 | 0.094 |
- Citation: Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc 2021; 13(9): 371-381
- URL: https://www.wjgnet.com/1948-5190/full/v13/i9/371.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i9.371